MarketPulse

medical supplies

7 articles
BenzingaBenzinga··Globe Newswire

Embecta Initiates Quarterly Dividend, Signals Confidence in Insulin Delivery Business

Embecta initiates quarterly $0.01-per-share dividend payable June 2026, signaling financial stability and shareholder capital return confidence.
EMBCdividendcash dividend
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Embecta Gears Up for Q2 2026 Earnings as Insulin Delivery Leader Faces Market Pressures

Embecta Corp. (EMBC) schedules May 5, 2026 earnings call to discuss Q2 2026 results and operational updates amid competitive insulin delivery market pressures.
EMBCconference callinvestor relations
The Motley FoolThe Motley Fool··Selena Maranjian

Becton Dickinson Emerges as Defensive Healthcare Play for Income-Focused Investors

BDX offers 2.7% dividend yield, 50+ years of annual growth, and valuation discount amid healthcare sector headwinds.
BDXvaluationdividend growth
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Zynex Shareholders Face Total Wipeout as Bankruptcy Follows $85M Fraud Settlement

Zynex filed for Chapter 11 bankruptcy after losing Tricare payments and settling federal fraud allegations for $85M, triggering securities class action and near-total equity loss.
ZYXIQsecurities fraudclass action lawsuit
BenzingaBenzinga··Hagens Berman Sobol Shapiro Llp

Zynex Faces Securities Lawsuit After Bankruptcy, Fraud Settlement in Medical Billing Scandal

Zynex faces securities class action lawsuit following bankruptcy, $85M fraud settlement, and delisting after alleged systematic overbilling scheme.
ZYXIQsecurities fraudclass action lawsuit
BenzingaBenzinga··Hagens Berman Sobol Shapiro Llp

Zynex Bankruptcy Sparks Securities Class Action After $85M Fraud Settlement

Zynex files for bankruptcy after fraud settlement; class action lawsuit filed against medical device maker over alleged oversupply scheme. Lead plaintiff deadline: April 21, 2026.
ZYXIQsecurities fraudclass action lawsuit
BenzingaBenzinga··Hagens Berman Sobol Shapiro Llp

Zynex Collapse Triggers Securities Class Action After $85M Fraud Settlement

Securities lawsuit filed against Zynex following bankruptcy, delisting, and $85M fraud settlement. Executives indicted for healthcare fraud.
ZYXIQsecurities fraudclass action lawsuit